• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Are tiny ‘supermagnets’ the future of drug delivery?

November 14, 2016 By Sarah Faulkner

Are tiny 'supermagnets' the future of drug delivery?Researchers from Quingdou University of Science and Technology in China developed a method to produce “supermagnets” that could one day be used as targeted drug delivery vehicles. The team’s work was published in Physics Letters A. 

Some magnetic materials are small enough that their magnetization randomly flips according to temperature; when scientists apply a magnetic field to these crystals, the material becomes almost as strongly magnetic as an ordinary fridge magnet. This type of magnetism, called superparamagnetism, is the strongest known type of magnetism.

Superparamagnetic particles could be directed to a tumor using a magnetic field, making them ideal vehicles for drug delivery. The supermagnets’ tiny size previously made them impossible to guide precisely, but the Quingdou team’s particles are large enough to control with external fields.

The researchers said that the high temperature and high pressure under which the crystals form create irregularities in the crystal lattice of the supermagnets. These irregularities are responsible for the magnetic properties that make the supermagnets a potential method of drug delivery. Most magnetic crystals of a similar size that are grown at lower temperature and normal pressure conditions are only weakly magnetic.

“The largest superparamagnetic materials that we have been able to make before now were clusters of nanocrystals that were together about a thousand times smaller than these,” co-author Kezheng Chen said in prepared remarks. “These larger crystals are easier to control using external magnetic fields, and they will not aggregate when those fields are removed, which will make them much more useful in practical applications, including drug delivery.

Filed Under: Drug-Device Combinations, Featured, Oncology, Research & Development Tagged With: Quingdou University of Science and Technology

IN CASE YOU MISSED IT

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS